Supreme Court limits patents on genes

In a unanimous ruling Thursday, the Supreme Court said that human genes cannot be patented. The decision left open the possibility that Myriad Genetics could patent DNA, although not genes that it simply isolates and extracts from the body. The case involved patents on mutations linked to increased risk of breast and ovarian cancer.

View Full Article in:

USA Today · New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA